Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

CELLULOSE ACETATE CRS (40 MG)

CELLULOSE ACETATE CRS (40 MG)

9004-35-7

DISCOVER
ROSMARINIC ACID CRS (50 MG)

ROSMARINIC ACID CRS (50 MG)

20283-92-5

DISCOVER
CAFFEINE FOR SYSTEM SUITABILITY CRS (10 MG)

CAFFEINE FOR SYSTEM SUITABILITY CRS (10 MG)

58-08-2

DISCOVER
INDINAVIR CRS (100 MG)

INDINAVIR CRS (100 MG)

157810-81-6

DISCOVER
FEXOFENADINE HYDROCHLORIDE CRS (110 MG)

FEXOFENADINE HYDROCHLORIDE CRS (110 MG)

153439-40-8

DISCOVER
VINPOCETINE IMPURITY C CRS (15 MG)

VINPOCETINE IMPURITY C CRS (15 MG)

NA

DISCOVER
FLUOROURACIL IMPURITY MIXTURECRS (0.0002 MG)

FLUOROURACIL IMPURITY MIXTURECRS (0.0002 MG)

NA

DISCOVER
POLY(VINYL ACETATE) DISPERSION 30 PER CENT CRS (1500 MG)

POLY(VINYL ACETATE) DISPERSION 30 PER CENT CRS (1500 MG)

9003-20-7

DISCOVER
VINYL ACETATE CRS (100 MG)

VINYL ACETATE CRS (100 MG)

108-05-4

DISCOVER
GLYCEROL MONOCAPRYLATE CRS (400 MG)

GLYCEROL MONOCAPRYLATE CRS (400 MG)

NA

DISCOVER
GLYCEROL MONOCAPRYLOCAPRATE  CRS (500 MG)

GLYCEROL MONOCAPRYLOCAPRATE CRS (500 MG)

NA

DISCOVER
FLUORESCEIN CRS (120 MG)

FLUORESCEIN CRS (120 MG)

05/07/2321

DISCOVER